Market Research Future
Ophthalmoplegia Market by Value, Revenue, Segments, Mega trends, Prominent Players and Outlook to 2023 Ophthalmoplegia Market Scenario: Ophthalmoplegia refers to the condition of double or blurred vision due to damage of the ophthalmic nerves. It can be caused by congenital abnormalities, trauma, viral infections, or disorders that affect the nervous system including multiple sclerosis, cerebral tumors, and migraines. Diabetes is one of the major cause of ophthalmoplegia. Increasing prevalence of ophthalmoplegia, increasing geriatric population, and changing lifestyle are the major driver for the growth of the market. Moreover, increasing prevalence of diabetes & other neurological diseases, and increasing government support for research & development have fuelled the market growth. However, high cost of the treatment may hinder the growth of the market over the assessment period. Request Free Sample copy at https://www.marketresearchfuture.com/sample_request/4216 The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023. Market Players of Global Ophthalmoplegia Industry: Some of key players profiled in the report are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant Pharmaceuticals International, Inc. (US), Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson (US). Ophthalmoplegia Market Segments: The global ophthalmoplegia market has been segmented on the basis of types, treatments, and end users. On the basis of types, the market is segmented into external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia is further segmented into superior recti, inferior recti, medial recti, lateral recti, inferior oblique, and superior oblique muscles. On the basis of treatments, the market is segmented into surgery, drug treatment, and others. The surgery is further segmented into strabismus surgery and others. On the basis of end users the market is segmented into hospital & clinics, ambulatory clinics, and others.